U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07397338) titled 'Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors' on Feb. 02.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of RAS(ON) inhibitors in combination with ivonescimab in adults with advanced or metastatic solid tumors with a RAS mutation.
Study Start Date: Jan. 30
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Metastatic Solid Tumors
Non-small Cell Lung Cancer (NSCLC)
NSCLC
Colorectal Cancer (CRC)
CRC
Intervention:
DRUG: Daraxonrasib
oral tablets
DRUG: Elironrasib
oral tablets
DRUG:...